| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |